![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » WYETH FACES FIRST TRIAL OVER HORMONE REPLACEMENT THERAPY
WYETH FACES FIRST TRIAL OVER HORMONE REPLACEMENT THERAPY
July 26, 2006
Linda Reeves thought it was a good idea to take hormone replacement therapy to help prevent the osteoporosis that plagued her mother. But doubts surfaced six years ago when she was diagnosed
with breast cancer and her doctor instructed her to stop taking the pills.
Newsday
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
21Oct